Bristol-Myers Squibb Company

Bristol-Myers Squibb Companyverified

BMY

Price:

$40.97

Market Cap:

$83.05B

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphi...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1972-06-01

Stock Exchange

NYSE

Ticker

BMY

The ROE as of June 2024 (TTM) for Bristol-Myers Squibb Company (BMY) is -23.01%

According to Bristol-Myers Squibb Company’s latest financial reports and current stock price. The company's current ROE is -23.01%. This represents a change of 73.27% compared to the average of -13.28% of the last 4 quarters.

Bristol-Myers Squibb Company (BMY) Historical ROE (quarterly & annually)

How has BMY ROE performed in the past?

The mean historical ROE of Bristol-Myers Squibb Company over the last ten years is 14.63%. The current -23.01% ROE has changed -257.28% with respect to the historical average. Over the past ten years (40 quarters), BMY's ROE was at its highest in in the September 2018 quarter at 13.94%. The ROE was at its lowest in in the March 2024 quarter at -72.23%.

Quarterly (TTM)
Annual

Average

14.63%

Median

16.48%

Minimum

-23.78%

Maximum

35.29%

Bristol-Myers Squibb Company (BMY) ROE by Quarter and Year

Discovering the peaks and valleys of Bristol-Myers Squibb Company ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 311.50%

Maximum Annual ROE = 35.29%

Minimum Annual Increase = -456.83%

Minimum Annual ROE = -23.78%

Quarterly (TTM)
Annual
YearROEChange
202327.27%33.87%
202220.37%4.69%
202119.46%-181.81%
2020-23.78%-456.83%
20196.66%-81.12%
201835.29%311.50%
20178.58%-68.87%
201627.55%142.03%
201511.38%-15.63%
201413.49%-20.22%

Bristol-Myers Squibb Company (BMY) Average ROE

How has BMY ROE performed in the past?

The current ROE of Bristol-Myers Squibb Company (BMY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

22.36%

5-year avg

10.00%

10-year avg

14.63%

Bristol-Myers Squibb Company (BMY) ROE vs. Peers

How is BMY’s ROE compared to its peers?

Bristol-Myers Squibb Company’s ROE is less than AbbVie Inc. (55.33%), less than Merck & Co., Inc. (5.84%), less than Gilead Sciences, Inc. (2.32%), less than Johnson & Johnson (53.97%), less than Eli Lilly and Company (53.53%), greater than Pfizer Inc. (-0.31%), less than Amgen Inc. (58.59%), less than Biogen Inc. (7.92%),

CompanyROEMarket cap
55.33%$299.63B
5.84%$322.93B
2.32%$80.07B
53.97%$351.25B
53.53%$841.12B
-0.31%$152.88B
58.59%$162.69B
7.92%$32.97B

Build a custom stock screener for Bristol-Myers Squibb Company (BMY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bristol-Myers Squibb Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bristol-Myers Squibb Company (BMY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bristol-Myers Squibb Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Bristol-Myers Squibb Company's ROE?

How is the ROE calculated for Bristol-Myers Squibb Company (BMY)?

What is the highest ROE for Bristol-Myers Squibb Company (BMY)?

What is the 3-year average ROE for Bristol-Myers Squibb Company (BMY)?

What is the 5-year average ROE for Bristol-Myers Squibb Company (BMY)?

How does the current ROE for Bristol-Myers Squibb Company (BMY) compare to its historical average?